Join
Live feed
·
INSIDERFilingvia Quantisnow
UroGen Pharma Ltd. logo

General Counsel Smith Jason Drew converted options into 3,334 units of Ordinary Shares and sold $64,618 worth of Ordinary Shares (1,519 units at $42.54), increasing direct ownership by 4% to 53,141 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.